secwatch.observer — SEC 8-K summary
======================================

Issuer:     BRAINSTORM CELL THERAPEUTICS INC. (BCLI)
CIK:        0001137883
Form:       8-K
Filed at:   2023-07-19T23:59:59+00:00
Accession:  0001104659-23-082342
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BrainStorm Cell Therapeutics announces $7.5M registered direct offering of common stock and warrants
--------------------------------------------------------------------------------

- 4,054,055 shares at $1.85 each, each with a warrant to purchase one share at $2.00 for five years.
- Gross proceeds of ~$7.5M before placement agent fees and expenses.
- Closing expected July 19, 2023; Maxim Group LLC is sole placement agent.
- Offered under existing S-3 shelf registration statement (File No. 333-258640).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1137883/000110465923082342/0001104659-23-082342-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1137883/000110465923082342/tm2321519d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-082342

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer